Search hospitals > Pennsylvania > Pittsburgh
University of Pittsburgh Cancer Institute (UPCI)
Claim this profilePittsburgh, Pennsylvania 15232
Global Leader in Parotid Gland Cancer
Global Leader in Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Melanoma
1081 reported clinical trials
86 medical researchers
Summary
University of Pittsburgh Cancer Institute (UPCI) is a medical facility located in Pittsburgh, Pennsylvania. This center is recognized for care of Parotid Gland Cancer, Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Melanoma and other specialties. University of Pittsburgh Cancer Institute (UPCI) is involved with conducting 1,081 clinical trials across 797 conditions. There are 86 research doctors associated with this hospital, such as Liza C. Villaruz, Jason Luke, MD, Diwakar Davar, MD, and Adam Brufsky, MD.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage II
2Cancer
Global LeaderStage IV
Stage III
Stage I
Top PIs
Liza C. VillaruzUniversity of Pittsburgh Cancer Institute (UPCI)6 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
40 reported clinical trials
59 drugs studied
Jason Luke, MDUniversity of Pittsburgh Medical Center1 year of reported clinical research
Expert in Cancer
Expert in Solid Tumors
39 reported clinical trials
67 drugs studied
Diwakar Davar, MDUPMC Hillman Cancer Center7 years of reported clinical research
Expert in Melanoma
Studies Cancer
34 reported clinical trials
48 drugs studied
Adam Brufsky, MDUniversity of Pittsburgh Cancer Institute (UPCI)1 year of reported clinical research
Expert in Breast Cancer
Expert in Breast cancer
31 reported clinical trials
70 drugs studied
Clinical Trials running at University of Pittsburgh Cancer Institute (UPCI)
Lung Cancer
Skin Cancer
Non-Small Cell Lung Cancer
Parotid Gland Cancer
Cancer
Breast Cancer
Prostate Cancer
Melanoma
Kidney Cancer
Pancreatic Cancer
FF-10832 + Pembrolizumab
for Cancer
To confirm a recommended Phase 2 dose (RP2D) of FF-10832 (Gemcitabine Liposome Injection) given intravenously Day 1 of a 21-day cycle, in combination with 200 mg pembrolizumab given intravenously Day 1 of the same 21-day cycle, for treatment of advanced urothelial and non-small cell lung cancer
Recruiting3 awards Phase 2
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of Pittsburgh Cancer Institute (UPCI)?
Where is University of Pittsburgh Cancer Institute (UPCI) located?
Who should I call to ask about financial aid or insurance network?
What insurance does University of Pittsburgh Cancer Institute (UPCI) accept?
What awards or recognition has University of Pittsburgh Cancer Institute (UPCI) received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.